356
Views
9
CrossRef citations to date
0
Altmetric
Drug Evaluations

Everolimus tablets for patients with subependymal giant cell astrocytoma

, MD, , MD PhD, , MD, , MD, , MD & , MD
Pages 2265-2269 | Published online: 01 Aug 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Liangliang Shi, Zhenwei Zou, Qian Ding, Qing Liu, Hongxia Zhou, Xiaohua Hong & Gang Peng. (2019) Successful treatment of a BRAF V600E-mutant extracranial metastatic anaplastic oligoastrocytoma with vemurafenib and everolimus. Cancer Biology & Therapy 20:4, pages 431-434.
Read now

Articles from other publishers (7)

Xiaoling Song, Yifan Wu, Xiaojuan Qu & Biao Jiang. (2023) Applications of macrocyclic molecules in cancer therapy: Target cancer development or overcome drug resistance. MedComm – Oncology 2:3.
Crossref
Mark R Woodford, Sarah J Backe, Rebecca A Sager, Dimitra Bourboulia, Gennady Bratslavsky & Mehdi Mollapour. (2021) The Role of Heat Shock Protein-90 in the Pathogenesis of Birt-Hogg-Dubé and Tuberous Sclerosis Complex Syndromes. Urologic Oncology: Seminars and Original Investigations 39:6, pages 322-326.
Crossref
Tara Dobson & Vidya Gopalakrishnan. (2018) Preclinical Models of Pediatric Brain Tumors—Forging Ahead. Bioengineering 5:4, pages 81.
Crossref
James W. Wheless & Paul KlimoJrJr. (2013) Subependymal Giant Cell Astrocytomas in Patients With Tuberous Sclerosis Complex:. Journal of Child Neurology 29:11, pages 1562-1571.
Crossref
Ching-Shiun Ke, Hsiao-Sheng Liu, Cheng-Hsin Yen, Guan-Cheng Huang, Hung-Chi Cheng, Chi-Ying F. Huang & Chun-Li Su. (2014) Curcumin-induced Aurora-A suppression not only causes mitotic defect and cell cycle arrest but also alters chemosensitivity to anticancer drugs. The Journal of Nutritional Biochemistry 25:5, pages 526-539.
Crossref
Birgit Geoerger & Heike Blockus. (2013) Everolimus for astrocytomas in tuberous sclerosis complex. The Lancet 381:9861, pages 95-96.
Crossref
N. F. Marko & R. J. Weil. (2012) The molecular biology of WHO grade I astrocytomas. Neuro-Oncology 14:12, pages 1424-1431.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.